The largest local drugs manufacturer in Kazakhstan - Chimpharm (Santo) joins Polpharma Group.

The first laboratories were opened in a biotech centre in the Gdansk Science and Technology Park.

Polpharma acquired a majority stake in Polfa Warszawa S.A.

The company Sanfarm, based in the Tarnobrzeg Special Economic Zone, became part of Polpharma S.A. Pharmaceutical Works. Following the merger of the two companies, Polpharma’s Manufacturing Division in Nowa Deba

Polpharma opened a Representative Office in Vietnam.

Polpharma started a strategic joint venture cooperation in the area of biotechnology with the German company Neuraxpharm

Polpharma published the first CSR report according to the Global Reporting Initiative (GRI) guidelines.

Polpharma celebrated its 80th anniversary. To mark this occasion, it organised the Polrun relay race.

Construction began of a new biological drug production plant for external clients in Duchnice

A new investment was launched in Sieradz: construction of the new Non Sterile Fluid Plant increased the production capacity of current drugs and enabled the introduction of further products from

Polpharma took first place in the XI I Ranking of Responsible Companies the most important list of leaders of social responsibility and sustainable development in Poland. For the first time

According to the decision of the Supervisory Board of Polpharma S.A., the process of separating the Biotechnology Department from the Pharmaceutical Works Polpharma S.A. was completed. As a result, Polpharma

The first commercial series of the drug manufactured in the new Medana production department, belonging to the Polpharma Group, was released for trading. This way, the company completed a 4-year